glp 1 oral pill Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk Ro Launches Wegovy® Pill Through

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Read important safety and prescribing info on this page.

GLP-1 drugs like Ozempic have transformed weight loss in the U.S., with nearly 12% of Americans having tried them, according to a new RAND report

Starting Jan.1, 2026, Pennsylvania will limit GLP1 weightloss drugs under Medicaid threatening access for thousands of lowincome patients.

The literature is replete with dozens of such reports, reporting fascinating findings, yet lingering uncertainty as to how these actions are achieved.

Explore how Tirzepatide and Semaglutide differ in weight loss and glucose control